Shunten International (Holdings) Ltd.

Shunten International (Holdings) Ltd.

HHKEX:932
0.04
HKD
+0.00
(-2.38%)
96.34MMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.1
0.11
0.09
0.11
0.13
0.16
0.13
0.09
0.05
0.07
0.08
0.07
0.06
- -
Basic EPS, GAAP
- -
0.02
0.01
0.01
-0.07
- -
-0.06
-0.05
-0.02
0.01
- -
-0.01
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
-0.01
-0.01
- -
0.01
- -
- -
0.01
0.01
- -
- -
Dividend per Share
- -
0.01
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.08
0.09
0.09
0.1
0.05
0.08
0.06
0.01
0.03
0.05
0.06
0.04
0.04
0.04
Tangible Book Value per Share
0.08
0.09
0.09
0.1
-0.13
-0.12
0.04
- -
0.03
0.04
0.05
0.04
0.03
0.03
Basic Weighted Avg Shares
1,786
2,060
2,065
2,083
2,115
2,123
2,364
2,564
2,877
3,108
3,108
3,108
3,108
3,108
Sales/Revenue/Turnover
170
228
190
221
264
332
304
223
156
216
236
205
200
- -
Operating Margin (%)
-0.95
17.52
8.42
7.34
-25.17
-20.14
-9
6.56
-0.44
16.96
10.91
1.67
-3.91
- -
Depreciation Expense
2
2
3
5
13
16
20
13
8
7
9
12
11
- -
Net Income, GAAP
-6
32
10
13
-139
-4
-140
-127
-44
41
1
-36
-27
- -
Effective Tax Rate (%)
1,382.55
21.03
29.28
24.41
- -
458.84
- -
- -
- -
5.92
88.68
- -
- -
- -
Profit Margin (%)
-3.38
13.84
5.49
5.77
-52.64
-1.31
-45.97
-57.08
-28.2
18.99
0.24
-17.68
-13.27
- -
Working Capital
151
160
123
158
137
-233
51
-58
-66
-95
-80
-75
-50
-50
LT Debt
- -
- -
- -
- -
325
64
95
9
- -
4
6
6
- -
- -
Total Equity
168
181
179
214
167
208
133
19
103
143
172
135
109
109
Return on Invested Capital (%)
-6.63
17.65
5.33
5.37
- -
-15.03
- -
- -
- -
20.09
0.53
- -
- -
- -
Return on Capital (%)
-6.63
17.86
5.39
6.19
- -
-13.26
- -
- -
- -
20.26
0.57
- -
- -
- -
Return on Common Equity (%)
-5.55
18.06
5.78
6.51
-85.19
-3.14
-91.7
-155.56
-69.55
32.68
0.36
-23.42
-21.53
- -

Capital Structure

HKD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
ST Debt
123
119
89
LT Borrowings
- -
- -
- -
LT Finance Leases
6
2
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3,108
3,108
3,108
Market Capitalization
75
103
96

Working Capital

HKD

•

in mil. unless spec.
Mar'25
Sep'26
Mar'26
Total Current Assets
70
102
67
Cash, Cash Equivalents & STI
6
11
7
Accounts Receivable, Net
37
37
36
Inventories
25
24
22
Total Current Liabilities
146
153
117
Payables & Accruals
- -
- -
- -
ST Debt
123
119
89
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
35.79%
91.59%
-19.54%
Free Cash Flow
66.85%
167.44%
-42.66%
Net Income, GAAP
-499.15%
-1,366.33%
-26.69%
Sales/Revenue/Turnover
2.89%
0.47%
-2.32%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
236
2025
- -
- -
205
2026
- -
- -
200

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
-0.01
2026
- -
- -
-0.01

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Wai Lok Yeung
Full Time Employees
236
Sector
Consumer non-durables
Industry
Household/Personal care
Address
KC100 Hong Kong Hong Kong
IPO Date
Oct 11, 2013
Business
Shunten International (Holdings) Limited is a Hong Kong-based investment holding company principally engaged in the development, manufacture, marketing, sale, trade, and distribution of health and beauty supplements and products, operating primarily in Hong Kong and mainland China. The company offers a diverse portfolio under proprietary brands including Royal Medic, Legend, MeltyEnz, CleansingEnz, La Gusto, HARUKA, Mr. 75, and Health Proof, alongside private label products developed for prominent retail chains in Hong Kong and Macau. Its product range spans health supplements, skincare items, and wellness-related consumables, supplemented by original equipment manufacturing, general administrative, and management services. Additionally, Shunten International operates a property investment segment involving the leasing of commercial, residential, and industrial properties, as well as license and trademark holding. Founded in 2011 and headquartered in Kwai Chung, Hong Kong, the company was previously known as RM Group Holdings Limited before its rebranding in 2018. In recent developments, Shunten International has launched multiple new products and upgraded versions of best-selling items during 2024-2025, including Dr Immune, Prof Gut Brain, Prof Sleep, Legend Allergic Skin Care Patch, Royal Medic NMN Prime 32000+, Haruka Fish Oil 800 Plus, and Health Proof Vitamin C, aiming to enhance its market offering and brand image. The company has intensified advertising and promotional efforts to support these new launches despite rising raw material and packaging costs. Furthermore, Shunten underwent a significant ownership change in 2025 when Chairman Zhang Shaohui and related parties acquired approximately 48.8% of the company's issued shares, triggering a mandatory conditional cash offer for remaining shares. The company continues its strategic emphasis on expanding sales channels, optimizing cost structure, and exploring sustainable growth while maintaining a solid liquidity position. This includes leveraging e-commerce platforms alongside traditional retail networks to broaden its customer base domestically and internationally. Shunten International operates within the personal care and health supplement industry segments, targeting consumers interested in wellness, health maintenance, and beauty enhancement. Its geographic operations cover the Hong Kong market with extensions into mainland China and Macau, employing a multi-brand and private label strategy to cater to diverse retail channels. The company also engages in property leasing and investment activities as part of its broader business portfolio, contributing to its revenue streams. Noteworthily, Shunten International's recent operational focus has been on innovation in product development and market expansion, supported by strategic acquisitions of stakes by institutional investors, which reflect confidence in its growth potential. Overall, Shunten International (Holdings) Limited represents a multi-faceted enterprise in the health and beauty sector, combining product innovation with property investment and strategic shareholding changes to consolidate its market position and enhance long-term shareholder value. It continues to navigate competitive pressures and changing consumer preferences with a commitment to sustainable growth and operational efficiency.